Graphical Abstract Highlights d Elucidation of the interface of full-length STAT1 and a viral interferon antagonist d The viral protein-STAT1 interface involves multiple distinct surfaces d Ablation of the interaction requires multiple mutations at distinct sites d Loss of viral protein-STAT1 interaction attenuates a rabies virus street strain
In Brief
Hossain et al. explore the binding surface of the multifunctional P-protein of rabies virus for STAT1, a protein that is essential for establishing the antiviral response of infected cells. They identify a complex interface comprising several distinct sites and demonstrate that targeted modifications of these can significantly attenuate pathogenic virus.
SUMMARY
To evade immunity, many viruses express interferon antagonists that target STAT transcription factors as a major component of pathogenesis. Because of a lack of direct structural data, these interfaces are poorly understood. We report the structural analysis of full-length STAT1 binding to an interferon antagonist of a human pathogenic virus. The interface revealed by transferred cross-saturation NMR is complex, involving multiple regions in both the viral and cellular proteins. Molecular mapping analysis, combined with biophysical characterization and in vitro/in vivo functional assays, indicates that the interface is significant in disease caused by a pathogenic field-strain lyssavirus, with critical roles for contacts between the STAT1 coiled-coil/DNA-binding domains and specific regions within the viral protein. These data elucidate the potentially complex
INTRODUCTION
The type I interferon (IFN) system comprises the earliest response of host cells against viral infection (Nan et al., 2017; Randall and Goodbourn, 2008; Versteeg and García-Sastre, 2010) . Following infection, cells release IFNs that bind type I IFN receptors to activate the signal transducers and activators of transcription (STAT) family members STAT1 and STAT2 via phosphorylation of conserved tyrosines. This results in activation of IFN-stimulated genes (ISGs), products of which include antiviral and immunomodulatory proteins that establish an antiviral state and facilitate adaptive responses.
In resting cells, STATs are generally unphosphorylated (U-STAT) antiparallel dimers, but following activation phosphorylated STATs (pY-STAT) form parallel dimers that enter the nucleus to activate ISGs (Lim and Cao, 2006) . pY-STAT1/2 are the major mediators of type I IFN signaling. Within the nucleus, pY-STAT1/2 complexes with IFN-regulatory factor 9 (IRF9) bind to IFN-stimulated response elements (ISREs) in ISG promoters. pY-STAT1 homodimers are also activated by type I IFN, and bind distinct g-activated sequences (GASs). Although pY-STAT signaling has formed the focus of research, U-STATs also mediate gene transcription relevant to immunity, cell proliferation, and cancer (Cheon et al., 2013; Yang and Stark, 2008) .
Viruses have numerous strategies to overcome the IFN response, mediated principally by viral IFN antagonist proteins. Given their central roles in responses to cytokines including IFNs, it is not surprising that many IFN antagonists interfere with STATs, especially STAT1 by diverse mechanisms (Audsley and Moseley, 2013; Ito et al., 2016; Nan et al., 2017; Versteeg and García-Sastre, 2010) . Because of the importance of IFN in controlling infections, it has been assumed that mechanisms of IFN antagonism play essential roles in pathogenesis (Fensterl and Sen, 2009; Versteeg and García-Sastre, 2010) . Studies using recombinant viruses defective in specific IFN antagonist mechanisms are limited, but an analysis of rabies virus (RABV) and measles virus (Devaux et al., 2011; Wiltzer et al., 2014) containing mutations inhibiting IFN antagonist/STAT1 interaction indicated important roles, suggesting that this interface could provide targets for antiviral drugs or vaccine development. However, the precise nature of the interaction sites remains largely unresolved because of a lack of direct structural data on STAT1 complexes with viral proteins; thus, most data come from mutagenic studies, interpretation of which is particularly difficult for multifunctional viral proteins. P-protein is the main IFN antagonist of lyssaviruses, which comprise a genus of highly pathogenic viruses, including RABV that causes rabies with a case fatality rate of $100% . In common with many other IFN antagonists, P-protein targets both IFN induction and signaling (Brzó zka et al., 2005; Ito et al., 2016) . The latter involves interaction with STAT1 (Vidy et al., 2005; Wiltzer et al., 2012) , which was originally identified by yeast-two-hybrid analysis, suggesting a direct interaction, and causes mislocalization of pY-STAT1 out of nuclei via nuclear export and cytoskeletal association of P-protein isoforms (Brice and Moseley, 2013; Ito et al., 2010; Moseley et al., 2009; Wiltzer et al., 2012) . Using recombinant RABV containing mutated P-protein, these antagonistic mechanisms were correlated with pathogenicity (Brice et al., 2016; Ito et al., 2010 Ito et al., , 2016 Wiltzer et al., 2014) . P-protein is also an essential replication co-factor via interaction with nucleocapsid (N) protein associated with genomic RNA (N-RNA) and the polymerase (L-protein). Thus, P-protein is a complex multifunctional protein.
The globular C-terminal domain of P-protein (P-CTD) contains sites required for binding to STAT1 (Vidy et al., 2005; Wiltzer et al., 2014) and N-RNA (Schoehn et al., 2001) and so is central to replication and immune evasion functions. Despite this, the molecular details of P-CTD interactions are poorly understood. The X-ray crystal structure was solved (Mavrakis et al., 2004) , and a model based on small-angle X-ray scattering (SAXS) data of the P-CTD/N-RNA complex was proposed (Ribeiro Ede et al., 2009 ). Yeast-two-hybrid experiments suggested that P-protein binds to the coiled-coil domain (CCD) and DNA-binding domain (DBD) region (CCD-DBD) of STAT1. Subsequent analysis of endogenous STAT1 in mammalian cell lysates with DNA probes containing STAT1-target sequences indicated that STAT1/DNA interaction can be inhibited by RABV infection or presence of full-length P-protein or its isoforms (Vidy et al., 2005 (Vidy et al., , 2007 . This suggests that P-CTD/STAT1-DBD interaction might compete with DNA; however, the minimal STAT1-binding region, P-CTD, has not been shown to be sufficient for inhibition of DNA interaction. Furthermore, confirmation that purified P-CTD and STAT1 interact, and that this directly inhibits STAT1-DNA binding in a cell-free system, has not been reported.
Recently, mutagenesis on the basis of sequence and functional analysis of P-proteins of different lyssaviruses indicated that changes to the ''W-hole,'' a hydrophobic cleft of P-CTD, can inhibit STAT1 interaction and thereby generate a viable but highly IFN-sensitive and attenuated RABV (Wiltzer et al., 2014) . Although these data suggest a role for the W-hole in the interface, this has not been demonstrated, and there is no direct structural data on any P-CTD complex.
In this study we use NMR spectroscopy to elucidate the STAT1-binding interface on P-CTD. Results indicate that the P-CTD/STAT1 complex comprises a discrete intermolecular interaction, by which P-CTD disrupts pY-STAT1/DNA binding. However, the interface did not include the W-hole and rather is extended, comprising several distinct regions in P-CTD that contact different STAT1 domains, indicating that IFN antagonist/ STAT complexes can involve extensive interfaces. Consistent with this, ablation of the interaction and antagonism of STAT1/ DNA binding/transcriptional activation required multiple mutations of different regions of P-CTD. The new mutations did not affect the fitness of a street strain virus in vitro but caused attenuation in vivo.
RESULTS

Expression, Purification, and Characterization of STAT1
Structural studies of STAT1 often use truncated protein (Oda et al., 2015) , perhaps reflecting expression and purification difficulties for full-length protein. To assess P-CTD/STAT1 interaction, we initially expressed full-length STAT1 as a glutathione S-transferase (GST) fusion. After purification and removal of GST, the yield was $2 mg with aggregates of >50% eluting in the void volume of size exclusion chromatography (SEC) (Figure S1A) . Furthermore, the purified protein almost immediately commenced precipitation at room temperature or within 8 h at 4 C, indicating poor stability.
We thus tested the GB1 fusion tag as a solubility enhancer (Zhou and Wagner, 2010) . STAT1 and a truncate comprising the CCD-DBD expressed with N-terminal GB1-and C-terminal His 6 tags showed that >80% of protein was in the soluble fractions after lysis, with yields after purification of $30 mg/L of culture. SEC showed little aggregation ( Figure S1A ); therefore the GB1 tag markedly enhances STAT1 expression, stability, and solubility, enabling >15-fold improvement in yield.
To assess the structural integrity of GB1-STAT1 or GB1-CCD-DBD, we used circular dichroism (CD) to show that the proteins were correctly folded ( Figure S1C ), with experimental secondary structure values fitting well with those calculated ( Figure S1D ). Sedimentation coefficient distributions c(s) from sedimentation velocity analytical ultracentrifugation (SV-AUC) indicated that GB1-STAT1 ( Figure S2A ) forms one major and two minor species; the major peak had a weight average coefficient of $6.5 S, corresponding to an expected dimer, and an estimated molecular weight of 187 kDa (theoretical mass 191 kDa) (Mao et al., 2005; Wenta et al., 2008) . The minor peaks ($3.7 S, $9.5 S) likely correspond to monomeric and multimeric STAT1. Sedimentation coefficients for GB1-CCD-DBD ( Figure S2B ) identified a major species with a sedimentation coefficient of $2.9 S, corresponding to a monomer, and an estimated molecular weight of 49 kDa (theoretical mass 50 kDa), consistent with the absence of the N-terminal domain (ND), which stabilizes U-STAT1 dimerization (Wenta et al., 2008) . The frictional ratios for GB1-STAT (1.7) and GB1-CCD-DBD (1.5) suggest asymmetrical, elongated shapes.
Direct interaction of P-CTD and STAT1 was suggested by yeast-two-hybrid experiments (Vidy et al., 2005) , although subsequent analyses have relied on microscopy or co-immunoprecipitation (coIP) using mammalian cells. To determine whether P-CTD/STAT1 interact directly in the absence of other cellular factors, and examine the molecular basis of such complexes, we expressed and purified the P-CTD of the Nishigahara RABV strain, tagged with GFP. Fluorescence-detected SV-AUC (FDS-AUC) experiments on GFP-P-CTD titrated with non-fluorescent GB1-STAT1 ( Figure S2C ) reveal a new peak at $7.4 S, attributed to a GFP-P-CTD/GB1-STAT1 complex. Titration using GB1-CCD-DBD ( Figure S2D ) revealed a decrease of the GFP-P-CTD peak and appearance of a new species at $3.7 S. Thus, the proteins interact directly; assuming 1:1 binding, and accounting for peak volumes of free and complexed GFP-P-CTD, we estimate an affinity (K D ) of $10-20 mM.
Mapping the STAT1 Interaction Site on P-CTD The above data are consistent with studies indicating that the STAT1-binding site is in the P-CTD (Vidy et al., 2005; Wiltzer et al., 2014) , and provide evidence that this involves a discrete interaction with the CCD-DBD. As the AUC experiments showed P-CTD binds weakly to U-STAT1, we acquired transferred crosssaturation NMR data using 15 N, 2 H P-CTD and 14 N, 1 H GB1-STAT1 or GB1-CCD-DBD ( Figure 1 ). Three regions of P-CTD were attenuated with GB1-STAT1: I201-F209 (region A), D235-K237 (region B) and L276-V277 (region C), suggesting an extended interface, but with GB1-CCD-DBD, only resonances from regions A and B were attenuated. Previous studies using cell lysates indicated that RABV or P-protein can suppress inter- Figure 1 . Identification of STAT1-Binding Sites on P-CTD (A) Intensity ratios of NH resonances from on-and offresonance saturation 15 N, 1 H transverse relaxationoptimized spectroscopy (TROSY) of 15 N, 2 H P-CTD plotted against residue number and secondary structure for apo-P-CTD (no STAT1, black), in the presence of GB1-STAT1 (magenta), and GB1-CCD-DBD (green). With GB1-STAT1, intensity for H203, I205, A206, E207, and D235 reduces to <0.5 (unbroken line) and for I201, Q204, F209, D236, I237, L276, and L277 reduces to within 0.6-0.5 (dashed line). Residues contributing to interactions lie within helices 1, 2, and 5 of P-CTD. W265 and M287 are indicated. action of endogenous STAT1 with DNA probes (Vidy et al., 2007) , potentially via direct interaction at the CCD-DBD. Our data support direct bi-molecular interaction at this site, and indicate specific regions (A/ B) in P-CTD form this interface, enabling direct assessment of their functional importance.
Residues of all regions are highly conserved among lyssaviruses ( Figure S3 ). Regions A and B are distant in the sequence, but proximal in the folded domain. Nevertheless, they are likely to form quite distinct interactions with the CCD-DBD, as region A sits centrally in the round face, and region B sits on the edge of the round and flat faces, so that side chains of residues of region B point in the opposite direction to those of region A (Figure 1D ). Region C is distant from regions A/B and does not contact the CCD-DBD, suggestive of alternative roles or contribution to overall binding affinity. Previous experiments indicated that mutation of W-hole residues W265G/M287V inhibit binding and antagonism of STAT1, and viral pathogenesis (Wiltzer et al., 2014) , suggesting the W-hole might form part of the binding site. The W-hole sits centrally in the flat face, on the opposite side to region A, and distant from regions B and C. Our data, including the lack of any attenuation of N ε H of W265 ( Figure 1C ), indicate that binding does not directly involve the W-hole.
Mutational Analysis of the Interface
To examine roles of regions A, B and C in antagonizing STAT1mediated transcription, point mutations were introduced into full-length Nishigahara P-protein (Ni-P) and antagonism of cellular IFN-STAT1 signaling assessed using a reporter assay as previously described (Vidy et al., 2005; Wiltzer et al., 2012 Wiltzer et al., , 2014 . Ten residues (Table 1) were selected on the basis of the degree of attenuation of resonances and surface exposure (Figure 1) . Controls included wild-type (WT) P-protein of CVS RABV (CVS-P), which strongly antagonizes STAT1, and CVS-P deleted for the C-terminal 30 residues (PD30), a standard control deficient in STAT1 targeting and replication function (Vidy et al., 2005; Wiltzer et al., 2014) . As expected, WT Ni-P suppressed IFN signaling (indicated by reduction of IFN-dependent induction of luciferase to $3% of that observed for PD30), while Ni-P containing W-hole mutations W265G and M287V, previously shown to impair antagonism by CVS-P, was clearly defective (Table 1) .
Analysis of single mutations indicated modest effects for F209A ($36% that for PD30), D235A and D235K ($11%-14%), and A206E ($6%). As shown for CVS-P (Wiltzer et al., 2014) , Ni-P containing W265G or M287V alone was partially defective ($11%). Other single mutations showed little to no evident impact (Table 1) . Mutations altering size, polarity, or charge (D235K, L276E) did not substantially differ from alanine mutations, although A206E appeared moderately defective compared with A206G, which had no apparent impact (Table 1) . Dual mutation of surface residues of region A (D235/D236) had a greater effect than single mutants, but this remained moderate ($29%), whereas mutation of L276/L277 of region C gave no clear effect. These data indicate that discrete changes to individual regions are insufficient to strongly suppress STAT1 antagonism, consistent with interaction via multiple contacts. Nevertheless, certain mutations in region A or B could partially reduce antagonism of STAT transcriptional function, perhaps consistent with roles in binding the CCD-DBD, supporting a key role of this interaction in immune evasion (Vidy et al., 2005) . Although region C is clearly attenuated by full-length STAT1, mutations to this region were not sufficient to significantly affect transcriptional inhibition in this screen, consistent with region C binding outside of the CCD-DBD and unlikely to affect DNA binding. Thus, region C may play different roles in STAT1 targeting and/or represent a minor binding site for the N-or C-terminal regions of the same STAT1 protein bound by region A/B, or for a site within the opposing monomer of dimeric STAT1, as dimerization is not possible for the CCD-DBD truncate because of the absence of the ND (Wenta et al., 2008) .
On the basis of the data indicating significance of regions A and B, we analyzed effects of mutations affecting both regions, combining mutants that had partial effects individually. A206E/ D235K produced a substantially greater effect than either mutation alone (62%), while F209A/D235A ablated antagonism (96%) ( Table 1) ; importantly, western analysis of lysates indicated that defects caused by these mutations are not due to altered P-protein expression ( Figure S4 ). The potent effect of mutations affecting both regions compared with changes to individual regions is consistent with the extensive interface predicted using NMR.
Notably, despite a substantial effect of W265G/M287V, it retained some antagonist function (81% that of PD30), and we consistently observed a significantly greater defect by F209A/ D235A (p = 0.0175, Student's t test). These data suggest that the latter mutations have more potent impact on STAT1 interaction, consistent with their placement within predicted binding regions. F209A/D235A was thus selected for further analysis.
F209A/D235A Mutation Prevents P-CTD-STAT1 Interaction
To confirm that the effect of F209A/D235A on STAT1 antagonism was due to altered binding, we tested interaction of the isolated P-CTD and STAT1 proteins in vitro using NMR. A two-dimensional (2D) 15 N, 1 H heteronuclear single quantum coherence (HSQC)-monitored titration of 15 N-WT P-CTD with equimolar GB1-STAT1 resulted in an average of 52% loss of resonance intensity for 88 well-resolved peaks (Figure 2A ). Despite relatively strong inhibitory effects on antagonist function of P-protein in signaling assays (Table 1) , W265G/M287V P-CTD produced similar broadening patterns to WT (average 41% loss of Results of screens using an IFN-dependent luciferase reporter assay to assess antagonist function of the indicated P-proteins expressed in HEK293-T cells treated without (À) or with (+) IFN. Data are from multiple screens, so normalized luciferase activity is shown as a percentage of the internal positive control for each assay (IFNa-treated CVS PDC30expressing cells). Data from each individual assay are the mean of triplicates; where multiple assays were performed, n values (in parentheses) indicate the number of biological replicates used to calculate mean ± SD. ND, not done. a Solubility of P-CTD expressed from E. coli.
intensity, 83 peaks) ( Figure 2B ). In contrast, F209A/D235A P-CTD produced little broadening (average 7% loss of intensity, 85 peaks) ( Figure 2C ). Thus, although W265G/M287V reduces STAT1 binding, F209A/D235A lacks detectable binding, consistent with the data indicating that regions A and B are critical (Table 1) .
To confirm that effects on isolated protein interactions correlate with interactions in cells, we used coIP and confocal laser scanning microscopy (CLSM) analysis. The original identification of P-protein/STAT1 interaction (Vidy et al., 2005) indicated that STAT1-CCD-DBD is sufficient to mediate binding in the absence of activation by tyrosine phosphorylation, as the tyrosine is in the transactivation domain (TAD; Figure S1B ). However, several studies show that efficient interaction detected by coIP from cells requires IFN activation (Brzó zka et al., 2006; Wiltzer et al., 2012) . Consistent with this, WT Ni-P, but not PD30, co-precipitated STAT1 from cells treated with IFN for 0.5 h ( Figure 3A ) (Wiltzer et al., 2012 (Wiltzer et al., , 2014 . In agreement with the lack of antagonistic function and binding in NMR, Ni-P F209A/D235A replicated the phenotype of PD30, showing no detectable interaction (Figure 3A , IP: lane FD).
CLSM analysis ( Figure S5 ) of the localization of immunostained STAT1 in cells expressing GFP-fused WT and mutant Ni-P indicated that, as expected, STAT1 rapidly accumulated into nuclei following IFN activation (0.5 h), and this was prevented by WT Ni-P (Ito et al., 2010) . Consistent with complete loss of STAT1 antagonism, F209A/D235A Ni-P did not inhibit STAT1 nuclear translocation.
Our data indicate that W265G/M287V retains significant capacity to bind STAT1 in vitro (Figure 2 ) but is strongly defective in antagonism of IFN/STAT1 signaling in cells (Table 1; Figure 3A) . Consistent with retention of binding, at least at early time points (0.5 h) of IFN treatment, W265G/M287V Ni-P suppressed IFNdependent STAT1 nuclear translocation ( Figure S5 ). coIP assays also indicated W265G/M287V Ni-P interacted with STAT1 at (A-C) WT (A), W265G/M287V (B), and F209A/D235A (C) 15 N-P-CTD (30 mM) titrated with GB1-STAT1 (30 mM); intensity differences are shown in histograms. Portions of 15 N, 1 H HSQC spectra for P-CTD proteins with (multiple contours, red) and without (single contour, black) GB1-STAT1. Spectra are plotted at the same levels. 0.5-1 h IFN treatment when cellular pY-STAT1 levels are maximal ( Figure 3A) ; however, in multiple assays, binding was clearly reduced compared with WT Ni-P. Furthermore, although WT Ni-P retained STAT1 binding over extended periods (>16 h, as expected; Wiltzer et al., 2014) , binding was lost for W265G/M287V. P-protein causes cytosolic accumulation of pY-STAT1 in cells, most likely because of retention in antagonistic complexes that prevent dephosphorylation by nuclear phosphatases, which ordinarily occurs from 0.5-1 h IFN treatment as a negative regulatory mechanism (Brzó zka et al., 2006; Wiltzer et al., 2012) (Figure 3A , input lanes). Thus P-protein prevents normal phosphorylation/dephosphorylation recycling (Brzó zka et al., 2006) , which presumably enables sustained antagonism. Our data indicate that W265G/M287V Ni-P is defective both for initial binding affinity and for retention of pY-STAT1 (Figure 3A) , accounting for defective antagonism. Nevertheless, it clearly has residual STAT1 interaction compared with F209A/ D235A Ni-P, explaining incomplete loss of antagonist function (Table 1) . As the NMR data indicate that W265 and M287 are not a part of the binding region, the effects of the mutations are likely indirect via conformational effects. In contrast, F209A/D235A Ni-P is as potent as PD30, consistent with specific removal of critical STAT1 contacts.
Structural Analysis of Mutated P-CTD
To assess conformational effects of F209A/D235A or W265G/ M287V, we purified P-CTD containing single or double mutants. Although all single mutants and F209A/D235A expressed as soluble proteins (>60%) ( Table 1) , W265G/M287V expressed largely into the pellet fraction (10% in the lysis supernatant), consistent with the idea that defective STAT1 antagonism may be due to loss of proper folding. We next 13 C, 15 N labeled WT and mutant P-CTD, assigned the 15 N, NH, 13 Ca, 13 Cb, and C 0 resonances, and assessed secondary structure differences. Secondary structure of WT was consistent with the crystal structure of CVS P-CTD (Mavrakis et al., 2004) , and there were no significant differences between WT and mutant proteins ( Figure 4A ). However, comparison of the 1 H-15 N average chemical shifts of mutant and WT proteins ( Figure 4C ) showed that, in addition to the expected changes near sites of mutation, W265G/M287V produced changes to distant regions suggesting an impact on the overall fold.
To assess protein stability, we conducted hydrogen-deuterium exchange experiments. Within the time course of the experiment, we determined the exchange rates for a number of amide protons of WT P-CTD (Table S1 ). In general, F209A/D235A shows faster exchange for all amides compared with WT. For well-resolved resonances for which exchange rates for both WT and F209A/D235A could be determined, differences in free energy for unfolding (dDG) were estimated to be 4.5-11.3 kJ$mol À1 (Table S1 ). Remarkably, for W265G/M287V, com-plete hydrogen-deuterium exchange had occurred by the first time point ($20 min), suggesting global destabilization.
We also performed thermal unfolding monitored by CD. The full CD spectra and estimated secondary structure of P-CTD are similar for WT and F209A/D235A ( Figure S6A ). Although secondary structure content and the shape of the spectra of W265G/M287V were similar to WT and F209A/D235A, the minima were distinctly different. Unfolding of P-CTD shows the WT and F209A/D235A fit to a two-site unfolding model (T m = 57.0 ± 0.2 C and 51.0 ± 0.7 C, respectively) ( Figures S6B and S6C ). However, W265G/M287V fits poorly to a two-state model (estimated T m = 46 C) ( Figure S6D) .
Collectively, these data indicate that the conformation of W265G/M287V is significantly and globally destabilized compared with WT and F209A/D235A, supporting the idea that W265G/M287V affects STAT1 antagonism via off-target effects, while F209A/D235A disables the interface (region A/B) that binds into the CCD-DBD.
P-CTD Interaction Directly Disrupts STAT1-DNA Binding
The finding that mutations specifically affecting regions A/B prevent P-protein from antagonizing STAT1 transcription suggested that specific contacts with the CCD-DBD, and consequent inhibition of STAT1/DNA interaction, are critical. To examine effects of WT and mutated P-CTD on STAT1/DNA binding in the absence of other cellular factors, we assessed pY-STAT binding to a DNA fragment containing GAS sequences. pY-STAT1 induced a strong concentration-dependent shift in electropho-retic mobility, with most of the DNA becoming arrested in the well at a pY-STAT1:DNA ratio of 1.2:0.2 mg, with only a minor population of lower shifted DNA still apparent within the gel (Figure 3B) ; WT or mutated P-CTD alone caused no apparent shift of the DNA fragment mobility. Pre-incubation of pY-STAT1 with increasing amounts of WT was clearly inhibitory, preventing arrest of DNA in the well indicative of disruption of the major pY-STAT1/DNA interaction. In contrast, F209A/D235A had little to no impact at any concentration tested, supporting importance of regions A/B in binding to the DBD. W265G/M287V also lacked inhibitory activity, consistent with conformational effects reducing STAT1-binding capacity to a level insufficient to disrupt the interaction. Although WT clearly disrupted the major, strongly shifted pY-STAT1/DNA complex, the lower shifted DNA population remained evident, and appeared more distinct in DNA samples incubated with complexes of WT P-CTD/pY-STAT1 than pY-STAT1 alone or pre-incubated with mutated P-CTD. This is likely indicative of non-specific protein/DNA interactions, possibly through weak electrostatic interactions of the WT P-CTD/pY-STAT1 complex with DNA. Clearly, however, these data indicated that the minimal STAT1-binding region of P-protein, P-CTD, is sufficient to disrupt the major pY-STAT1/ DNA interaction. This supports a mechanism whereby formation of discrete P-CTD/STAT1 complexes, not requiring other viral/ cellular proteins, antagonizes specific STAT1/DNA interaction, consistent with the direct blockade of the DBD.
F209A/D235A Does Not Interfere with Other Essential P-Protein Functions
Mutagenic studies suggest that the N-RNA binding site of P-protein is a cluster of basic residues (K211, K212, R260) formed by the P-CTD fold (Jacob et al., 2001; Wiltzer et al., 2014) . Consistent with distal localization to the W-hole, W-hole mutations did not substantially affect replication (Wiltzer et al., 2014) . However, the N-RNA binding site is proximal to region A (Figure 1 ) and so could be affected by F209A. To assess this, we expressed a peptide (N-peptide) corresponding to a disordered region of N-protein (residues 363-414), which was suggested to mediate P-CTD/ N-RNA interaction in a SAXS model (Ribeiro Ede et al., 2009) . Two-dimensional 15 N, 1 H HSQC-monitored titrations of 15 N-Npeptide with WT and mutant P-CTDs showed significant chemical shift differences in N-peptide ( Figure 5A) , which fitted to a singlesite binding curve ( Figure 5B ). WT and F209A/D235A showed similar affinities, while W265G/M287V showed >2-fold loss of affinity ( Figure 5B ). Thus, although W265G/M287V P-CTD clearly retains significant binding to N-protein, permitting normal virus replication (Wiltzer et al., 2014) , these data support global structural effects of this mutant. To confirm that N-peptide binding correlates with replication function, we used a minigenome assay in which functional L-protein/P-protein/N-RNA interaction is indicated by luciferase activity (Wiltzer et al., 2014) (Figure 5C ). Despite ablation of STAT1 antagonist function, replication function of F209A/D235A P-protein was equivalent to that of WT.
Other than antagonizing IFN signaling, P-protein inhibits IFN induction in infected cells by antagonizing the RIG-I-like receptor pathway (Brzó zka et al., 2005; Masatani et al., 2016; Wiltzer et al., 2014) . The responsible site(s) in P-protein are not known, but the C-terminal region 152-297 is suggested to be important (B and C) Average chemical shift differences ( 1 H, 15 N) between WT and W265G/M287V (B) or F209A/D235A (C) P-CTD. Insets show differences >0.1 ppm mapped onto CVS P-CTD. Sites of mutations indicated by arrows; W265G chemical shift difference is 2.4 ppm (not shown) (B). (Masatani et al., 2016; Rieder et al., 2011) . To determine whether F209A/D235A affects this function, we assessed RIG-I signaling using a reporter assay (Audsley et al., 2016) , finding no effect of F209A/D235A or W265G/M287V (the latter consistent with data for CVS-P (Wiltzer et al., 2014) ) ( Figure 5E ). Thus, the new mutations specifically affect the STAT1 targeting arm of P-protein IFN antagonism.
F209A/D235A Mutation Attenuates Street Strain RABV
To assess the role of the STAT1-binding surfaces in infection, we used a recombinant RABV based on the Tha street strain (Thongcharoen et al., 1990) . To confirm the potency of mutations in inhibiting STAT1 interaction by Ni-and Tha P-protein (Tha-P), we used a protein-fragment complementation assay (PCA) with a ''split'' luciferase reporter to measure interactions in cells transfected with WT or mutant P-proteins and STAT1 ( Figure 6A) . Consistent with the NMR data, normalized luminescence ratio (NLR) values from PCA assays of WT Ni-P/STAT1 interaction in non-IFN-treated cells were comparable with the commonly used threshold of 3.5 for significant interaction (Cassonnet et al., 2011) . As NLR values for Ni-P F209A/D235A were clearly reduced ($7-fold), it appears that Ni-P can interact with STAT1 in non-activated cells, dependent on interaction with the CCD-DBD via region A/B. As expected, the NLR for WT Ni-P/STAT1 increased substantially ($3-fold) following IFN treatment. In contrast, values for Ni-P F209A/D235A did not approach the 3.5 threshold. These data are consistent with our findings that interaction with both U-STAT1 ( Figure 1 ) and pY-STAT1 (Figure 3A) is dependent on these residues of regions A/B forming the interface with the CCD-DBD. Assays using Tha-P were comparable with those for Ni-P, confirming conservation of the contact sites ( Figure 6A ).
We next generated Tha virus encoding WT (Tha-WT) or F209A/D235A-mutated (Tha-FD) P-protein. Assays of virus production in IFN-incompetent BSR cells indicated no difference between Tha-WT and Tha-FD ( Figure 5D ), consistent with a lack of effect of mutations on replication ( Figure 5C ). Infection of STING-37 cells that stably express an IFN-dependent luciferase gene, before treatment without or with IFN ( Figure 6B ), indicated that Tha-WT strongly inhibits luciferase activity in IFN-treated cells compared with that in mock-infected cells. However, in cells infected by Tha-FD, luciferase activity in untreated and IFN-treated cells was not significantly different to that in IFN-treated mock-infected cells, indicating that Tha-FD cannot prevent STAT1 signaling in response to endogenous IFN induced by infection, or exogenous IFN. Consistent with these data, Tha-FD showed significantly impaired pathogenesis compared with Tha-WT following intramuscular inoculation of mice ( Figure 6C ). As replication in BSR cells was not impaired for the mutant virus, these data are consistent with reduced pathogenesis due to defective evasion of host immunity. 
DISCUSSION
Although inhibition of STAT1-mediated IFN signaling is a common mechanism of many pathogenic viruses, the nature of the interaction sites formed between viral proteins and STAT1 remains largely unresolved because of a lack of structural data and consequent reliance on mutagenesis (Nan et al., 2017) . To our knowledge, only one crystal structure has been reported for a viral protein with STAT1, comprising a short N-terminal fragment of STAT1 with C-protein of a rodent virus, Sendai virus (Oda et al., 2015) . For human pathogens, mass spectrometry hydrogen-deuterium exchange experiments mapped a potential interaction site for truncated STAT1 (residues 1-683) on Ebola virus VP24 (Zhang et al., 2012) . However, VP24 antagonism of STAT1 is reported to be due to VP24-importin interaction, which prevents importin-dependent STAT1 nuclear import, with roles for the suggested VP24/STAT1 interaction currently not supported by cell-based studies (Xu et al., 2014) . Therefore there is a paucity of structural data on the interface of a viral protein with full-length STAT1.
Our NMR data indicated an extended, complex interface in P-CTD containing three regions, two of which (A and B) form direct contacts with STAT1-CCD-DBD, while the distant region C forms distinct interaction involving the N-and/or C-terminal domains. This interface is in contrast to the small W-hole, mutation of which impaired STAT1 binding (Wiltzer et al., 2014) , but for which our NMR analysis did not indicate any contact with STAT1. Indeed, our data indicate that W-hole mutations indirectly reduce STAT1 binding through destabilization of the P-CTD. In contrast, our targeted mutagenesis of the interface identified mutations with localized effects that entirely prevent interaction. Our approach highlights the importance of validating results of mutagenic studies by biophysical approaches, particularly for multifunctional proteins such as IFN antagonists of RNA viruses, for which several similar mutagenic analyses have been reported (Ciancanelli et al., 2009; Rö thlisberger et al., 2010) .
By revealing the molecular basis of the specific interaction of the P-CTD with the CCD-DBD, our findings highlight the importance of this interface for STAT1 targeting and inhibition of its transcriptional function. Regions A and B, which bind the CCD-DBD, are proximally located on P-CTD but appear to form an extended interface, with each region likely to form distinct interactions with the CCD-DBD, as (1) region A is localized to the round face of the P-CTD, while region B is on the edge of the round and flat faces; (2) the side chains of the surface residues of the respective regions orient in opposite directions, suggesting contacts involve multiple, distinct sites in STAT1; and (3) ablation of STAT1 antagonism requires mutations that affect both regions. Furthermore, we showed that P-CTD alone, dependent on regions A/B, interferes directly with pY-STAT1/ DNA interaction in a cell-free assay. Together with previous findings from yeast-two-hybrid and mammalian cell-based assays, this indicates that specific targeting of the CCD-DBD by regions A/B is a major mechanism in immune evasion. Importantly, residues constituting each region of the new interface are conserved among lyssaviruses ( Figure S3 ), suggesting a common mechanism for STAT1 antagonism; furthermore, results from our NMR and mammalian cell-based analyses are consistent with the interface, including the critical binding to the CCD-DBD, being common to U-STAT1 and pY-STAT1. As residues of regions A and B point in opposite directions, it is possible that the IFN-dependent increase in binding to pY-STAT1 in coIPs results from the formation of different dimers by U-STAT1 and pY-STAT1. Specifically, while the binding sites are present in U-STAT1 and pY-STAT1, and can interact with P-CTD, formation of parallel dimers by pY-STAT1 may orient the sites to form simultaneous interactions with P-CTD via opposing monomers contacting regions A and B. Alternatively, pY-STAT1 might form more extensive interaction surfaces increasing affinity. (B) IFN-dependent luciferase assays of infected STING-37 cells treated without or with IFN (mean AU ± SD, n = 6 biological replicates; **p = 0.0012, ***p = 0.0002, and ****p < 0.0001, Student's t test). Delineation of these hypotheses forms the basis of ongoing research.
We previously showed that W265G/M287V renders laboratory RABV strains non-lethal after intracerebral inoculation, validating their potential to contribute to attenuation strategies to improve safety of live vaccines. However, the impact of mutations preventing STAT1 interaction has not been examined in street strains. Clearly, F209A/D235A prevented STAT1 interaction by Tha P-protein and STAT1 antagonism by Tha virus. These data demonstrate critical roles for P-protein/STAT1-CCD-DBD interaction in the immune evasion armory of street strain virus. Importantly, the mutation significantly attenuated pathogenicity of the street strain, indicating key roles in disease caused by high-pathogenicity virus. Nevertheless, the mutated virus retained residual pathogenicity; indeed this mutation does not impair antagonism of IFN induction ( Figure 5E ), which was reported to be more potent in street compared with fixed RABV strains (Masatani et al., 2016) . In addition, M-protein of street strains, but not fixed strains, affects NF-kB signaling, providing additional mechanisms to suppress IFN/cytokine responses (Besson et al., 2017; Luco et al., 2012) . The data, however, indicate that these substitutions provide new, minimally disruptive attenuating mutations, which could be used in combination with other mutations to improve the safety of vaccine strains.
Despite the proximity of the STAT1 and N-RNA binding sites in P-CTD (Chenik et al., 1994; Fu et al., 1994) , it appears that mutations can be introduced that specifically affect the former without detriment to the latter. Clearly, F209A/D235A produced very specific effects on STAT1 interaction and antagonism, with little to no effect on the affinity or function of N-protein interaction, demonstrating that STAT1 binding and virus replication are spatially distinct. Nevertheless, the proximity of region A of the STAT1-binding site and the predicted N-binding site suggest that binding to these proteins is tightly coordinated by P-protein, with the intriguing possibility that this results in regulation through steric or other mechanisms. Such a mechanism could provide the means for RABV, which has only five protein-encoding genes, to mediate efficient, dynamic coordination of immune evasion and replication during infection. In light of our findings, there is a clear need to extend understanding of P-/N-protein interaction beyond current mutagenic data and the ensuing SAXS models to define how such viruses regulate these functions. The molecular tools and approaches described in the present study should facilitate such research. Furthermore, our approach also has potential application for elucidation of other interactions of the multifunctional P-CTD, including with microtubules (Brice et al., 2016; Moseley et al., 2009) , nucleolin (Oksayan et al., 2015) , and importins/exportins (Rowe et al., 2016) . The methods developed to express, purify, and analyze the functions and interactions of full-length STAT1 should also provide tools for similar analyses of other viral antagonists or cellular regulators.
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